2VD-99003-81143
2 vaccinations
2 coded responses
20 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 830 / WY
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-26
- 2020-12-27
- 2020-12-31
- 2021-01-05
- 2021-01-12
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Headache — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Splitter headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-19
- 2021-02-25
- 2021-07-15
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-15 | priority 2/3 | |
| 2021-01-16 | priority 2/3 | |
| 2022-01-14 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Splitter headache
Release 10 — 12 months, dose 2
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release